Min Liu

Dr. Min Liu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2026 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
MLMin Liu
Min Liu
DMDe-Gang Mo
De-Gang Mo
JBJing-Xian Bai
Jing-Xian Bai
QHQian-Feng Han
Qian-Feng Han
HYHeng-chen Yao
Heng-chen Yao
Atherosclerosis, a leading cause of global mortality, is a chronic inflammatory disease driven by a vicious cycle of endothelial dysfunction, dysregulated lipid metabolism, and persistent inflammation. This review examines the mechanisms through which diverse triggers initiate the cycle. We discuss key cellular and molecular events, such as the detrimental phenotypic switching of vascular smooth muscle cells. We also describe the processes through which various upstream signals converge on core inflammatory hubs, such as the Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) pathway and the nucleotide-binding oligomerization domain, leucine-rich repeat-containing family, pyrin domain-containing-3 (NLRP3) inflammasome. By integrating these established mechanisms with recent findings on novel regulators, including the chemokine hemofiltrate CC chemokine 1 (HCC-1) and cell surface glycoRNA, this review identifies several potential new biomarkers. Overall, this review aimed to provide a comprehensive understanding of the pathogenesis of atherosclerosis, informing future research and the development of targeted interventions.



22 January 2026 in Cardiovascular Drugs and Therapy
Verified
Journal Article
Closed access
DMDe-Gang Mo
De-Gang Mo
MLMin Liu
Min Liu